Euroapi SA Financials

Euroapi SA Stock Summary

Euroapi SA competes with Ion Beam, Northwest Biotherapeutics, 3-D Matrix, BioPorto, and Clinuvel Pharmaceuticals. Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France. Euroapi Sa is traded on OTC Exchange in the United States.

Euroapi SA Key Financial Ratios

There are many critical financial ratios that Euroapi SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Euroapi SA reports annually and quarterly.

Euroapi Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Euroapi SA's current stock value. Our valuation model uses many indicators to compare Euroapi SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Euroapi SA competition to find correlations between indicators driving Euroapi SA's intrinsic value. More Info.Euroapi SA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Euroapi SA's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Euroapi SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Euroapi SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Euroapi SA based on widely used predictive technical indicators. In general, we focus on analyzing Euroapi Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Euroapi SA's daily price indicators and compare them against related drivers.

When running Euroapi SA's price analysis, check to measure Euroapi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Euroapi SA is operating at the current time. Most of Euroapi SA's value examination focuses on studying past and present price action to predict the probability of Euroapi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Euroapi SA's price. Additionally, you may evaluate how the addition of Euroapi SA to your portfolios can decrease your overall portfolio volatility.